web analytics
Sarah DeBoer, B.S., analytical chemist for Velesco Pharmaceutical Services

Sarah DeBoer, B.S. - Analytical Chemist

Scientific Leadership

Sarah DeBoer

 

Sarah DeBoer, B.S., Analytical Chemist and Scientific Leader for Velesco Pharmaceutical Services 

Sarah has ten years of pharmaceutical cGMP manufacturing experience with drug substances and drug products. She has worked in the pharmaceutical and medical device/OTC markets, testing raw materials, tablets, capsules, solutions and topical products. Sarah has extensive history in stability testing and analytical methods, ranging from compendial testing to analytical method development and cleaning validation. 

 

She previously spent six years at Ferndale Laboratories as Senior Chemist, working in stability testing, method development and validation and microbiology.  Sarah was responsible for maintaining the stability program, training and overseeing colleagues and working with other departments to provide stability data for FDA reporting and drug product development. 

 

Sarah holds a Bachelor of Science degree in Biology from Ball State University.

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!


Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!


Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.


In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.


Roundtable: M&A trends in CDMO - Molecule to Market


New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.


Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.


Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.


CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!


1 new job postings! Careers


Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.


Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100

734-274-9877